2017
DOI: 10.1128/aem.01313-17
|View full text |Cite
|
Sign up to set email alerts
|

Construction and Optimization of a Heterologous Pathway for Protocatechuate Catabolism in Escherichia coli Enables Bioconversion of Model Aromatic Compounds

Abstract: The production of biofuels from lignocellulose yields a substantial lignin by-product stream that currently has few applications. Biological conversion of lignin-derived compounds into chemicals and fuels has the potential to improve the economics of lignocellulose-derived biofuels, but few microbes are able both to catabolize lignin-derived aromatic compounds and to generate valuable products. While Escherichia coli has been engineered to produce a variety of fuels and chemicals, it is incapable of catabolizi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
50
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 50 publications
(54 citation statements)
references
References 45 publications
(31 reference statements)
2
50
0
Order By: Relevance
“…There is no a priori reason to expect that a pathway for degradation of an aromatic compound would interact with a native pathway for nucleotide biosynthesis. Phenolic amides such as feruloyl amide have been shown to inhibit a different step in nucleotide biosynthesis (Pisithkul et al, 2015), but neither the substrate nor products of coumarate degradation are toxic at the relevant concentrations (Clarkson et al, 2017; Standaert et al, 2018). These types of inhibitory cross-talk are likely to be common with introduced metabolic pathways, though they are rarely identified and alleviated (Kim and Copley, 2012; Kizer et al, 2008; Michener et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…There is no a priori reason to expect that a pathway for degradation of an aromatic compound would interact with a native pathway for nucleotide biosynthesis. Phenolic amides such as feruloyl amide have been shown to inhibit a different step in nucleotide biosynthesis (Pisithkul et al, 2015), but neither the substrate nor products of coumarate degradation are toxic at the relevant concentrations (Clarkson et al, 2017; Standaert et al, 2018). These types of inhibitory cross-talk are likely to be common with introduced metabolic pathways, though they are rarely identified and alleviated (Kim and Copley, 2012; Kizer et al, 2008; Michener et al, 2012).…”
Section: Discussionmentioning
confidence: 99%
“…As described previously, the pathway design used synthetic promoters, terminators, and custom ribosome binding sites (Chen et al, 2013; Espah Borujeni et al, 2014; Kosuri et al, 2013; Salis et al, 2009). Plasmids expressing sgRNA for chromosomal modifications were constructed as described previously, using an inverse PCR to linearize the expression vector followed by assembly with synthesized oligonucleotides (Clarkson et al, 2017). Plasmid pJM303, expressing the D243G mutant of the E. coli IMPDH, was constructed by amplifying the mutant guaB allele from JME89 and cloning it into pMCSG7 under the control of a T7 promoter.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…,128 For example, Sonoki et al116 and vanB encoding αand β-subunits respectively of vanillate demethylase, and catA encoding catechol dioxygenase) into the genome of E. coli so that the modified E. coli can produce muconic acid from vanillin. However, the decarboxylation reaction of protocatechuate remained a bottleneck and rate-limiting step as stated in previous studies 127.…”
mentioning
confidence: 99%